OMEGA_3A | R Documentation |
Kaplan-Meier digitized data from OMEGA, figure 3A (PMID 24504445). A reported sample size of 78 for a primary endpoint of PFS in breast cancer.
OMEGA_3A
A data frame of 78 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (cap, peg_doxorubicin) | |
Smorenburg CH, de Groot SM, van Leeuwen-Stok AE, et al. A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG. Ann Oncol 2014; 25: 599–605.
summary(OMEGA_3A)
kmplot(OMEGA_3A)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.